Federal Project Grant Award Summary

The National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859) awarded a $456,500 project grant to The University of Texas Southwestern Medical Center, effective July 3, 2026 through April 30, 2031. The award funds fundamental research investigating the dynamic mechanisms of human mitochondrial translation—the process by which mitochondria synthesize 13 essential proteins required for oxidative phosphorylation and ATP generation. The research employs in vitro reconstitution and single-molecule spectroscopy approaches to directly observe real-time translation dynamics by tracking individual dye-labeled ribosomal subunits, messenger RNAs (mRNAs), transfer RNAs (tRNAs), and protein factors. These investigative methodologies are intended to elucidate previously poorly understood mechanisms governing mitochondrial protein synthesis.

This research deliverable addresses critical knowledge gaps with direct applications to human health and therapeutic development. Understanding mitochondrial translation dynamics will enable more accurate interpretation of pathogenic mutations and inform the design of safer antibiotics that avoid inadvertent mitochondrial toxicity—a significant concern given the bacterial origin of the mitochondrial translation system. The findings are expected to advance understanding of disease mechanisms underlying cancer, metabolic syndrome, cardiovascular disorders, and neurodegenerative conditions in which mitochondrial dysfunction plays a pathogenic role. No sub-award arrangements are indicated in the award documentation.